This confidential internal partnership meeting deck, dated 6 August 2014, was prepared by Theranos for its retail pharmacy partner Walgreens. It opens with a title slide and a numbered agenda covering kick-off, current status, anchored values, success measures, the FY15 plan, California plans and standard testing. The status section presents store counts, launch waves and visit-time medians as plain bullets. A survey summary follows, with a headline stat slide, star-rating bar charts and pie charts for prescription sources and likelihood to return. Next comes a quote slide of patient comments, then tables of shortest and longest visit times by store. The opportunities section lists operational priorities, and a technician certification slide sets removal and reinstatement criteria. The Walgreens-branded middle section includes a business and change considerations matrix, a stakeholder model and a SMART goals table with owners and targets. The closing sections cover the FY15 market plan, a California T-minus schedule with a timeline graphic, and an IT phase plan with its scope. The deck ends with its phase 3 priorities.
Slides worth studying
- Slide 5: Small multiple bar charts with consistent axes and a single highlighted average give the survey results a clear, scannable form.
- Slide 36: A Gantt-style timeline lays out parallel workstreams across months with dated milestones, making a complex rollout readable at a glance.
- Slide 21: Three anchor words sit in a simple triangular arrangement with a short framing question, a restrained way to present a core message.
Questions about this deck
How many slides does the Theranos partnership meeting deck have?
The Theranos partnership meeting deck, dated 6 August 2014, is listed as having 39 pages. Slide 1 is the title slide, which opens the deck.
What does the Theranos deck say about current store status and median check-in time?
Slide 3 states that 30 stores are currently live (AZ 29; CA 1) and that the median check-in time is 5 min, a decrease of 1 min. The same slide reports total visits in August of 2637.
What does the Theranos survey summary report for overall experience?
Slide 4 reports 650 unique respondents for the period July 2 to August 4, 2014, with an average overall experience score of 4.85 stars. Slide 5 shows the bar chart for this overall experience rating.
What success criteria does the Theranos SMART goals slide list for patient experience?
Slide 27 lists a likelihood to come back of 90% or more by 8/31/15 and a referral by a friend or family member of 20% or more by 8/31/15. The same slide sets a training pass rate of 90% or more by 8/31/15.
Details
- Company: Theranos
- Year: 2014
- Type: Investor presentation
- Industry: Healthcare diagnostics
- Pages: 39
More from Theranos
- Theranos presentation, Meeting of the Board of Directors, 7.14.15
- Theranos, Inc. presentation, December 2010 board meeting
- Theranos, Inc. pitch deck, June 1, 2006 investor presentation
All Theranos decks in the library
Review score: 4 out of 10, Ineffective
Presentation quality, judged with the SlideDeck Co review heuristic. Ask, evidence and idea merit are not rated here.
The deck is a working-meeting artifact stitched from two organizations' templates, and the audience cannot follow a single argument through it. Many pages are repeated agenda trackers (slides 15, 16, 19, 24), several are dense tables set in tiny type that cannot be read at presentation size (slides 18, 22, 23), and slides 38 and 39 show clipped or empty-looking layouts. The survey charts on slide 5 and the timeline on slide 36 are legible and carry their point, but they sit among many slides with weak hierarchy, no takeaway titles and unexplained content such as the Venn on slide 21.
Worth keeping: Keep the survey bar charts on slide 5 with their direct value labels and average per chart, and the color-coded workstream bars of the timeline on slide 36.
Most useful repair: Cut the repeated change-management tracker slides, enlarge or split the stakeholder and matrix tables on slides 17, 18, 22 and 23, and fix the overlapping footers and the clipped table on slide 38.
What would change the score: I would rebuild the deck as one template with action titles that state each page's conclusion, so a reader gets a clear status, decisions needed and next steps without a presenter.
Confidence high. 39 of 39 pages inspected on contact sheets, 4 at readable size. Reviewed 2026-11-09. Model-assisted review (claude-sonnet-5-5).
Full text of the slides (39 slides)
Every slide's words and a description of its charts and images, so the deck can be searched and rebuilt. Also available as Markdown.
Slide 1
theranos
partnership meeting
08.06.14
this presentation and its contents are theranos property and confidential.
Trial Exh. 1884 Page 0017
1
Visuals: One logo: the theranos wordmark, about 33.5% wide by 11.0% high, placed at x 63.3, y 44.0. The letters are a bold, rounded grey sans-serif (#636466). The 'o' is replaced by a glossy teal-green sphere, shaded from pale mint at the top (#BFEDE0) to deeper green at the bottom (#1AAA82). No photographs, charts, or other graphics.
Slide 2
agenda
kick-off/introductions
Sunny/Nimesh
current status
Sunny/Nimesh
discuss anchored values
Mike
Lewis
discuss program measures of success
Nimesh
(SMART goals)
plan for FY15
Casey
california plans
Sunny/Nimesh
std testing
Sunny/Pat Carroll
Trial Exh. 1884 Page 0018
theranos confidential
2
Visuals: Non-photographic. The only graphic is the theranos logo (raster image, 138 by 26 pixels) at bottom right, wordmark in dark grey with a teal-green dot in place of the letter o. Bullets are solid round dots (●) in grey #646569. No charts, tables, photographs or diagrams.
Slide 3
current status
Sunny
30 stores currently live (AZ 29; CA 1)
wave 4 launch dates – Aug 19 and Aug 26 – stores TBD
total visits in August – 2637
27 out of 30 stores on DSL; Wave 4 wiring complete
TIFT team performing 65% of oversight visits
mostly improved patient experience
median check in time = 5 min – decr 1 min
median wait time = 7 min – incr 1 min
median perform time = 5 min – decr 2 min
total visit time = 17 min – decr 2 min
Trial Exh. 1884 Page 0019
theranos confidential
3
Slide 4
Theranos Experience Survey Summary
for period July 2 – August 4, 2014
Unique Respondents
650
Average Quality/Experience Scores
Overall Experience:
4.85 stars
Check In Process:
4.61 stars
Locating Theranos:
4.79 stars
Facilities:
4.79 stars
Sample Collection Process:
4.86 stars
Skill of Technician:
4.90 stars
Theranos Confidential
Trial Exh. 1884 Page 0020
Visuals: None apart from the theranos wordmark logo at bottom right: dark grey lowercase letters 'theranos' with the 'o' replaced by a teal-green dot. It is a small raster image (104 by 19 pixels), not cropped, not boxed, with no overlay.
Slide 5
Overall Experience
Check In Process
Locating Theranos
Facilities
600
500
400
300
200
100
0
1 4 4 6 47 556
600
500
400
300
200
100
0
0 1 2 3 4 5
Average: 4.85 stars
600
500
400
300
200
100
0
1 11 13 41 81 497
600
500
400
300
200
100
0
0 1 2 3 4 5
Average: 4.61 stars
600
500
400
300
200
100
0
0 5 6 20 51 534
Locating Theranos
0 1 2 3 4 5
Average: 4.79 stars
200
180
160
140
120
100
80
60
40
20
0
0 2 2 5 25 194
Facilities
0 1 2 3 4 5
Average: 4.79 stars
Theranos Confidential
Trial Exh. 1884 Page 0021
theranos
Visuals: Four vertical bar charts, each with 6 bars for star ratings 0 to 5 (x-axis label values 0,1,2,3,4,5; no axis titles, no units shown beyond stars in the averages). Y-axis gridlines light grey. Bars solid cyan blue #00A8E1 with no outlines; each bar carries a bold black value label above it. Chart 1 Overall Experience: y-axis 0 to 600 in steps of 100; values 0:1, 1:4, 2:4, 3:6, 4:47, 5:556; average 4.85 stars. Chart 2 Check In Process: y-axis 0 to 600 in steps of 100; values 0:1, 1:11, 2:13, 3:41, 4:81, 5:497; average 4.61 stars. Chart 3 Locating Theranos: y-axis 0 to 600 in steps of 100; values 0:0, 1:5, 2:6, 3:20, 4:51, 5:534; average 4.79 stars. Chart 4 Facilities: y-axis 0 to 200 in steps of 20; values 0:0, 1:2, 2:2, 3:5, 4:25, 5:194; average 4.79 stars. No legend. No highlighted points beyond the 5-star bar, which is tallest in each chart. The theranos logo is a wordmark in dark grey with a green dot replacing the o, boxed by nothing.
Slide 6
Sample Collection Process
Skill of Technician
600
558
700
600
500
500
400
400
300
300
200
200
100
100
36
1
5
2
10
0
0
0
1
2
3
4
5
0
1
2
3
4
5
1 5 1 7 22 577
Average: 4.86 stars
Average: 4.90 stars
Theranos Confidential
Trial Exh. 1884 Page 0022
Visuals: Two vertical bar charts. Left chart titled 'Sample Collection Process': y-axis 0 to 600 in steps of 100 with gridlines; x-axis categories 0, 1, 2, 3, 4, 5 (star ratings). Values per bar: 0 = 1, 1 = 5, 2 = 2, 3 = 10, 4 = 36, 5 = 558 (value labels printed above each bar, bold). Right chart titled 'Skill of Technician': y-axis 0 to 700 in steps of 100 with gridlines; x-axis categories 0 to 5. Values: 0 = 1, 1 = 5, 2 = 1, 3 = 7, 4 = 22, 5 = 577 (value labels printed above each bar, bold). Bars are solid #00A8E1 with no outline; no legend; no highlighted points. Below each chart is a bold average line: 'Average: 4.86 stars' (left) and 'Average: 4.90 stars' (right). Small theranos logo at bottom right, a wordmark in dark grey with a teal-green dot in place of the o.
Slide 7
Where do you typically get your prescriptions filled?
Walgreens
7%
1%
3%
3%
CVS
7%
Walmart
Costco
12%
53%
Target
Safeway
15%
Rite-Aid
Other
Theranos Confidential
Trial Exh. 1884 Page 0023
Visuals: One pie chart with no title of its own, no axes and no legend box beyond the vertical list at right. Eight slices, clockwise from 12 o'clock: Walgreens 53% (#00B28C, green, largest slice, spanning from 12 o'clock around the right and bottom to about 8 o'clock); CVS 15% (#00A8E1, blue); Walmart 12% (#FFDD00, yellow); Costco 7% (#FF671B, orange); Target 3% (#E6E7E8, light grey); Safeway 3% (#A7A9AC, mid grey); Rite-Aid 1% (#C00000, dark red, thin sliver); Other 7% (#8CE1FF, light sky blue, ending at 12 o'clock). Percentage labels are printed in bold black Arial on each slice: 53%, 15%, 12%, 7% (Costco), 3% (Target), 3% (Safeway), 1% (Rite-Aid), 7% (Other); the 1%, 3% and 3% labels sit close together near the top-left edge of the small slices. Legend at right lists in order Walgreens, CVS, Walmart, Costco, Target, Safeway, Rite-Aid, Other, each with a small square swatch in the slice colour. Slices have thin white or hairline separators. The theranos logo is a raster image (104 by 19 pixels): dark grey wordmark 'theranos' with a teal-green dot replacing the 'o'.
Slide 8
Based on your recent visit, what is the likelihood that you will return to a
Theranos Wellness Center?
1%
17%
Definitely coming back
Likely to return
Not sure if I will return
82%
Theranos Confidential
Trial Exh. 1884 Page 0024
theranos
Visuals: Pie chart, no printed chart title beyond the slide headline. Three slices, clockwise from 12 o'clock: 'Definitely coming back' 82% (green slice, the largest, covering most of the right and bottom-left of the circle), 'Likely to return' 17% (blue slice, upper-left quadrant between about 10 and 12 o'clock), 'Not sure if I will return' 1% (thin yellow slice just left of 12 o'clock). Percent labels are printed in black bold sans-serif inside or near each slice: 1% near the yellow slice, 17% inside the blue slice, 82% inside the green slice near the lower-right edge. No axes. Legend on the right with square colour swatches: green swatch beside 'Definitely coming back', blue swatch beside 'Likely to return', yellow swatch beside 'Not sure if I will return', listed top to bottom with even spacing. No highlighted points. Slice boundaries are thin, same-hue or hairline edges. Logo: the theranos wordmark in dark grey lowercase sans-serif with a teal-green gradient dot replacing the 'o', at bottom-right, about 8.1% wide.
Slide 9
Here’s what people are saying…
“Absolutely love the new technology Theranos has for blood tests. I will definitely let all my family and friends know about
your company.”
“Another fabulous experience! I didn't feel any pain, the procedure was so quick, and Tiffany was a delight! Thank you for
making the process of giving blood so easy and pleasant.”
“Best visit I have ever had. Amazing people they take really amazing care of people.”
“For a person who has severe phobia of needles and blood this was a pleasant experience all around.”
“This was the easiest lab test blood draw I’ve done in my life!”
“Fantastic experience! I couldn't even feel my skin being pierced; it was so easy. Thank you for inventing this to help people!”
“Easy and convenient! Can't beat the price.”
“Great customer service was provided at the Walgreens location lab today!”
Theranos Confidential
Trial Exh. 1884 Page 0025
theranos
Visuals: none apart from the theranos wordmark logo at bottom right: a dark grey lowercase wordmark 'theranos' in a bold sans-serif with the letter 'o' replaced by a small teal-green (#3BB39A approx.) filled circle, placed at x 88.8, y 94.0, 8.1 by 2.6 percent, 104 by 19 pixels.
Slide 10
shortest visit times
Median
Checkin
Time
(mins)
Name
WAG11610
4
WAG1272
4
WAG3132
4
WAG3177
4
WAG3464
4
WAG5668
4
Name
Median Wait
Time (mins)
WAG13596
5
WAG3477
5
WAG6582
5
WAG11610
6
WAG1272
6
WAG3132
6
WAG3657
6
WAG4188
6
WAG4508
6
WAG6060
6
Name
Median
Perform
Time (mins)
WAG13596
1
WAG3008
2
WAG3048
3
WAG5453
4
WAG2851
5
WAG3049
5
WAG3464
5
Trial Exh. 1884 Page 0026
theranos confidential
10
Visuals: No charts, photographs or illustrations. Three plain tables: Table 1 has columns Name and Median Checkin Time (mins) with 6 rows: WAG11610 4, WAG1272 4, WAG3132 4, WAG3177 4, WAG3464 4, WAG5668 4. Table 2 has columns Name and Median Wait Time (mins) with 11 rows: WAG13596 5, WAG3477 5, WAG6582 5, WAG11610 6, WAG1272 6, WAG3132 6, WAG3657 6, WAG4188 6, WAG4508 6, WAG6060 6. Table 3 has columns Name and Median Perform Time (mins) with 7 rows: WAG13596 1, WAG3008 2, WAG3048 3, WAG5453 4, WAG2851 5, WAG3049 5, WAG3464 5. Each table has a light grey horizontal rule under its header. One logo: the theranos wordmark in dark grey with a teal green dot in place of the o.
Slide 11
longest visit times / Name / Median Checkin Time (mins) / WAG2851 / 7 / WAG3008 / 7 / WAG4793 / 7 / WAG6060 / 7 / WAG6128 / 7 / WAG6697 / 7 / WAG1076 / 8 / WAG4188 / 8 / WAG4508 / 9 / WAG6582 / 9 / Name / Median Wait Time (mins) / WAG3048 / 8 / WAG3049 / 8 / WAG3177 / 8 / WAG3464 / 8 / WAG3912 / 8 / WAG6128 / 8 / WAG4793 / 9 / WAG3008 / 10 / WAG1076 / 12 / WAG6697 / 20 / Name / Median Perform Time (mins) / WAG6128 / 8 / WAG3912 / 9 / WAG5222 / 9 / WAG5504 / 9.5 / WAG4508 / 10 / WAG4793 / 10 / WAG6697 / 12 / Trial Exh. 1884 Page 0027 / theranos confidential / 11
Visuals: Three plain tables with no fills, no cell borders except a thin grey rule under each header row. Table 1 has columns Name and Median Checkin Time (mins) with rows WAG2851 7, WAG3008 7, WAG4793 7, WAG6060 7, WAG6128 7, WAG6697 7, WAG1076 8, WAG4188 8, WAG4508 9, WAG6582 9. Table 2 has columns Name and Median Wait Time (mins) with rows WAG3048 8, WAG3049 8, WAG3177 8, WAG3464 8, WAG3912 8, WAG6128 8, WAG4793 9, WAG3008 10, WAG1076 12, WAG6697 20. Table 3 has columns Name and Median Perform Time (mins) with rows WAG6128 8, WAG3912 9, WAG5222 9, WAG5504 9.5, WAG4508 10, WAG4793 10, WAG6697 12. Numeric values are right-aligned within their column. Row spacing is roughly 4.5% of slide height in the first table and slightly irregular in the others. One theranos wordmark logo at bottom right, dark grey lettering with a teal-green dot replacing the letter o, 138 by 26 px.
Slide 12
opportunities / Sunny / ● scalable strategy for check in / ● store by store – start with stores with 10+ patients per day / ● must start in August - will be tested during flu season / ● tight integration between HCC and Theranos check-in / ● call center knowledge of Theranos and communication to patients / ● assurance that 40% of stores will be dedicated space / ● improved staffing in all stores – surprises with Theranos tech shortages / ● need improvement in attentiveness of some stores / ● cleaning / ● attention to process – including opening and closing procedures / ● managing flow of patients / Trial Exh. 1884 Page 0028 / theranos confidential / 12 / theranos
Visuals: None apart from the corner logo: a Theranos wordmark at bottom right (x 86.7%, y 93.9%, 10.8% by 3.6% of the slide, 138 by 26 px). The word 'theranos' is set in a bold grey sans-serif, approximately #646569, with the letter 'o' replaced by a solid teal-green sphere, approximately #3BB39A, that sits on the baseline. The logo is unboxed and not cropped.
Slide 13
Certification Maintenance / 1. Criteria for removal of Certification / <80% fingerstick proficiency (Bi-Monthly) / Acting against established procedures (As reported) / 2. What happens next? / Technician becomes Check-In ONLY / Lead time to remove technician from live patient perform workflow (?) / 3. Reinstate Certification / Assess trainee using original oversight standards / At least 2 consecutive successful end-to-end visits / Idle Technicians / Technicians who perform <5 finger sticks in a given timeframe are required to complete / practice fingersticks / Trial Exh. 1884 Page 0029 / theranos confidential / 13 / theranos logo
Visuals: None apart from the theranos wordmark logo at bottom right: dark grey lettering reading 'theranos' in a bold sans-serif, with the letter o replaced by a glossy teal-green sphere (about #2BB59A) and a dark grey #5A5C5F wordmark; the logo is a raster image 138 by 26 pixels, unboxed and not cropped.
Slide 14
Diagnostic Testing – Theranos Partnership Change
Management Updates and Key Anchors Readout
• August 6, 2014
©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.
Trial Exh. 1884 Page 0030
Visuals: Logos only: (1) Walgreens red speech-bubble 'W' mark with a small trademark symbol, followed by the orange-and-grey 'CHANGE MANAGEMENT' wordmark with a stacked orange triangular stripe icon; (2) Walgreens red script wordmark over the tagline 'AT THE CORNER OF HAPPY & HEALTHY' in grey with green 'HAPPY' and blue 'HEALTHY'. The slide has no charts, photographs or diagrams; the rounded white panel and blue frame are background treatment.
Slide 15
Change Management Updates
• Change Management Updates
• Action Planning Exercise Results
• Key Anchors Discussion
• Readout from Discussion
• Next Steps
• Execute Against Change Management Action Planning Exercise Results
• Leveraging Key Anchors and Action Planning Exercise Results, Finalize FY15 Change
Strategy Draft
• Socialize FY15 Change Strategy
Trial Exh. 1884 Page 0031
©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.
15
Visuals: The only non-text visuals are the header band and the lower-left logo. The header is a flat, solid blue rectangle (image 1280 by 120 pixels) running full-bleed across the top 16.7% of the slide with no gradient, photograph or pattern. The logo is a red rounded square containing a white stylised 'w' mark with a small red tail at its lower-left, followed by a small orange chevron above the words 'CHANGE' and 'MANAGEMENT' in bold dark grey capitals stacked on two lines. No photographs, charts, tables or diagrams are present.
Slide 16
Change Management Updates
Change Management Updates
Action Planning Exercise Results
Key Anchors Discussion
Readout from Discussion
Next Steps
Execute Against Change Management Action Planning Exercise Results
Leveraging Key Anchors and Action Planning Exercise Results, Finalize FY15 Change Strategy Draft
Socialize FY15 Change Strategy
Trial Exh. 1884 Page 0032
©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.
16
CHANGE
MANAGEMENT
Visuals: Two logo images at the bottom left: a red rounded speech-bubble shape containing a white stylised script 'w' (Walgreens logo), and to its right a small orange-brown triangular mark followed by the words 'CHANGE MANAGEMENT' in dark grey bold sans-serif capitals on two lines. No charts, photographs or diagrams. The blue band is a flat rectangle with no gradient.
Slide 17
We Started Here: Business & Change Considerations Matrix Based on / Stakeholder Feedback
Recommended Focus Areas
Red = Short Term Recommended Actions
Purple = Both ST and LT Recommended Actions
Black = Long Term Recommended Actions
Definition of Success
Culture
Role Clarity
Business Readiness
Business Levers
Business Operations & Governance
• Clearly document decision rights & governance approach for partnership
• Further define short and long term success criteria
• Align business metrics to key behaviors
• Identify potential incentive alignment opportunities
• Reset “Pilot” vs. ““Initial Launch Market” expectations
• Identify common values shared by Walgreens and Theranos that can be leveraged to define success criteria
• Develop day to day interaction model that better pairs individuals across the partnership
• Define/align on Field, Corporate, and Theranos roles and responsibilities in the partnership
• Redefine/clarify roles for Kickoff Market vs. scale
• Further align governing bodies to decision making rights and escalation process
• Develop holistic Store Readiness checklist
• Define Pharmacy Workflow to incorporate scripts, WE, Theranos, and immunization services
• Develop pre-defined non-emergency SOP and app update calendar
• Define leading indicators to predict Program success
• Define scalable business model
Change Levers
Stakeholder Engagement, Communications, Organizational Alignment, and Training
• Align on communications strategy, plan, and execution with Theranos and field leadership
• Develop and measure additional training success criteria beyond pass rate
• Reframe “Pilot” vs. ““Initial Launch Market” language
• Develop and rally group behind both strategic and operational-level shared vision for the partnership
• Continue to incorporate Walgreens training principles, feedback and talent pool into training
• Leverage communications strategy recommendations (TBD)/agree on senders by message type
• Identify and develop district and store champions in existing and target markets
• Better align market/district leadership roles to training goals and focused value-add training activities
• Further enable TIFT team to realize team goals
• Facilitate SOP release approach alignment
• Identify best training practices and lessons learned from Kickoff Market to apply to scale
• Communicate Pharmacy Workflow to incorporate scripts, WE, Theranos, and immunization services
• Refine “T-minus” comms, Field Leadership Toolkit, and scenario planning exercises to better prepare field
• Measure business readiness based on lagging and leading indicators; recommend corrective actions
Trial Exh. 1884 Page 0033
©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.
17
Visuals: Table/matrix with 4 focus-area columns and 2 rows. Column headers (blue #56A0D3 cells): Definition of Success; Culture; Role Clarity; Business Readiness. Row 1 (Business Levers, light blue #D0DFEE): Definition of Success: Clearly document decision rights & governance approach for partnership (purple); Further define short and long term success criteria (black); Align business metrics to key behaviors (black); Identify potential incentive alignment opportunities (black). Culture: Reset “Pilot” vs. ““Initial Launch Market” expectations (red); Identify common values shared by Walgreens and Theranos that can be leveraged to define success criteria (purple); Develop day to day interaction model that better pairs individuals across the partnership (black). Role Clarity: Define/align on Field, Corporate, and Theranos roles and responsibilities in the partnership (red); Redefine/clarify roles for Kickoff Market vs. scale (black); Further align governing bodies to decision making rights and escalation process (black). Business Readiness: Develop holistic Store Readiness checklist (purple); Define Pharmacy Workflow to incorporate scripts, WE, Theranos, and immunization services (purple); Develop pre-defined non-emergency SOP and app update calendar (purple); Define leading indicators to predict Program success (black); Define scalable business model (black). Row 2 (Change Levers, pale #E9EFF7): Definition of Success: Align on communications strategy, plan, and execution with Theranos and field leadership (purple); Develop and measure additional training success criteria beyond pass rate (black). Culture: Reframe “Pilot” vs. ““Initial Launch Market” language (red); Develop and rally group behind both strategic and operational-level shared vision for the partnership (purple); Continue to incorporate Walgreens training principles, feedback and talent pool into training (purple). Role Clarity: Leverage communications strategy recommendations (TBD)/agree on senders by message type (red); Identify and develop district and store champions in existing and target markets (purple); Better align market/district leadership roles to training goals and focused value-add training activities (purple). Business Readiness: Further enable TIFT team to realize team goals (red); Facilitate SOP release approach alignment (purple); Identify best training practices and lessons learned from Kickoff Market to apply to scale (purple); Communicate Pharmacy Workflow to incorporate scripts, WE, Theranos, and immunization services (purple); Refine “T-minus” comms, Field Leadership Toolkit, and scenario planning exercises to better prepare field (purple); Measure business readiness based on lagging and leading indicators; recommend corrective actions (black). Colour key (legend, not a graphic): Red = Short Term Recommended Actions; Purple = Both ST and LT Recommended Actions; Black = Long Term Recommended Actions. Logo at bottom-left: the Walgreens red speech-bubble icon with a white stylised 'w' script, next to an orange chevron mark and the grey wordmark 'CHANGE MANAGEMENT' in two lines (CHANGE above MANAGEMENT). No photographs or illustrations.
Slide 18
We Discussed Each Consideration (and Agreed On An Action Plan for Each) Yesterday.
Example for “Definition of Success” Considerations Action Plan:
Business Levers
Recommended Action
Owner (of Next Steps)
Next Steps
Clearly document decision rights & governance approach for partnership
Patty, Mike, Casey
Christian
1) Discuss collaboration with Christian on 8/6
2) (Collaboratively) summarize Phoenix market approach, general partnership approach, and what future markets would look like
Further define short and long term success criteria
Tracy – to work at Store/Operational level
Casey, Mahesh, Mike (facilitate)
1) Follow up from 8/5 meeting key anchors discussion, 8/6 success criteria discussions
2) Tracy to document Theranos store/operational success criteria
Align business metrics to key behaviors
Mahesh, Mike
Leverage draft success criteria to align key behaviors/actions by role
Identify potential incentive alignment opportunities
Casey (working with workstream leads)
Theranos: future plan (past start-up mode)
Walgreens: Discuss potential approaches, timing with Casey
Change Levers
Recommended Action
Owner (of Next Steps)
Next Steps
Align on communications strategy, plan, and execution with Theranos and field leadership
Mike, Patty (to assist)
Document next iteration
Develop and measure additional training success criteria beyond pass rate
Mike, Ardith, John Look (to assist on reporting)
Joe, Ryan
Mike to set up brainstorming session with Joe, Ryan, Ardith, and John Look on possible success criteria
Trial Exh. 1884 Page 0034
©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.
1818
Visuals: Two tables, both pasted as images with a blue header row. Business Levers table (upper left, 759 by 317 px): columns Recommended Action, Owner (of Next Steps), Next Steps; rows: (1) Clearly document decision rights & governance approach for partnership (magenta text) | Patty, Mike, Casey / Christian | 1) Discuss collaboration with Christian on 8/6; 2) (Collaboratively) summarize Phoenix market approach, general partnership approach, and what future markets would look like; (2) Further define short and long term success criteria | Tracy – to work at Store/Operational level / Casey, Mahesh, Mike (facilitate) | 1) Follow up from 8/5 meeting key anchors discussion, 8/6 success criteria discussions; 2) Tracy to document Theranos store/operational success criteria; (3) Align business metrics to key behaviors | Mahesh, Mike | Leverage draft success criteria to align key behaviors/actions by role; (4) Identify potential incentive alignment opportunities | Casey (working with workstream leads) | Theranos: future plan (past start-up mode) / Walgreens: Discuss potential approaches, timing with Casey. Change Levers table (lower right, 896 by 264 px): columns Recommended Action, Owner (of Next Steps), Next Steps; rows: (1) Align on communications strategy, plan, and execution with Theranos and field leadership (magenta text) | Mike, Patty (to assist) | Document next iteration; (2) Develop and measure additional training success criteria beyond pass rate | Mike, Ardith, John Look (to assist on reporting) / Joe, Ryan | Mike to set up brainstorming session with Joe, Ryan, Ardith, and John Look on possible success criteria. The Walgreens CHANGE MANAGEMENT logo: a red rounded square with a white script W, beside an orange triangle and the dark grey wordmark CHANGE MANAGEMENT.
Slide 19
Change Management Updates
Change Management Updates
Action Planning Exercise Results
Key Anchors Discussion
Readout from Discussion
Next Steps
Execute Against Change Management Action Planning Exercise Results
Leveraging Key Anchors and Action Planning Exercise Results, Finalize FY15 Change Strategy Draft
Socialize FY15 Change Strategy
Trial Exh. 1884 Page 0035
©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.
19
Slide 20
Action Plan Next Steps
• Mike to Provide Full Action Plan Results to Group, Individuals Identified As / Owners (for All Four Focus Areas)
• Will Be Provided By End of Week
• Owners to Act Against Focus Areas
• Group to Identify Approach to Update Team
Trial Exh. 1884 Page 0036
©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.
20
Visuals: Non-text visuals: one flat blue header band (image, 1280 by 120 px, full width, top 16.7%, solid blue with no text or gradient) and one logo at bottom left (about 14.3% wide by 5.3% high). The logo shows a red rounded square containing a white stylised script 'W' (Walgreens mark) with a small red pointer at its lower left, followed by a small tan-orange chevron and the words CHANGE MANAGEMENT in bold dark grey sans-serif capitals stacked on two lines (CHANGE above MANAGEMENT). No charts, tables, photographs or diagrams.
Slide 21
Key Anchors Discussion / What could we ask a Pharmacy Technician to rally around, that is also meaningful to senior / leaders and others in our diverse stakeholder audience? / The common themes we agreed upon: / Pharmacy / Transformation / Patient Experience / [Scalable & Standardized] / Partnership / Relationship / Trial Exh. 1884 Page 0037 / ©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only. / 21
Visuals: Three overlapping ellipses forming a diagram. Left: a solid dark navy ellipse (#1E4164) at about x 11.1%, y 60.6%, w 24%, h 32%, containing the text 'Pharmacy / Transformation' in light blue. Centre: a larger ellipse at about x 31.7%, y 44.3%, w 33%, h 44%, filled navy #1E4164 at 60% opacity over a photographic network-of-nodes texture (thin connected lines and dot nodes in lighter blue-grey on blue facets), overlapping the left and right ellipses; it contains bold white 'Patient Experience' and white bold bracketed '[Scalable & Standardized]'. Right: an ellipse at about x 70%, y 43%, w 25%, h 34%, filled with a fine grey dot/hatch pattern (light grey on white), containing 'Partnership / Relationship' in navy text, which overlaps the centre ellipse's right edge. The logo is a red Walgreens 'W' mark in a speech-bubble shape with the grey 'CHANGE MANAGEMENT' wordmark featuring an orange triangle. No photographs apart from the network texture.
Slide 22
With These Anchors In Mind, We Discussed Some of the Behaviors and Actions We
Need to Ask of Our Stakeholders That Will Help the Program Realize Its Vision
Key Stakeholders like…
whose role is to…
…the Vision at the…
Should do/say/own
Brad Wasson
Rick Gates
Jeff Koziel
Nimesh Jhaveri
Elizabeth Holmes
Sunny Balwani
Define
Company level
Do:
Say:
Own:
Nimesh Jhaveri
Casey Kozlowski
Mahesh Raju
Sunny Balwani
Tracy Masson
Joe Ahdoot
Christian Holmes
Define
Program/ Partnership level
Do:
Say:
Own:
Matt Sesto
Brian Sizemore
Casey Kozlowski
Mahesh Raju
Tracy Masson
Kim Alfonso
Joe Ahdoot
Translate and reinforce
Kickoff Market level
Do:
Say:
Own:
DMs
RXSs
Sonia Cendejas
Operations Mgrs
Theranos Sales
Translate and reinforce
District level
Do:
Say:
Own:
CLs
TIFT Team
Sonia Cendejas
Operations Mgrs
Execute
Community level
Do:
Say:
Own:
MGRs
RXMs
Pharmacy Team
Theranos Phlebotomists
Operations Mgrs
Execute
Store level
Do:
Say:
Own:
IT
Finance
Call Center
Marketing
Theranos IT
Theranos Call Center
Support
Company, Program, and
Field levels
Do:
Say:
Own:
Trial Exh. 1884 Page 0038
©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.
22
Visuals: Table with five header cells and seven body rows. Header row (blue #56A0D3, white Calibri Bold): 'Key Stakeholders like…' spanning the first two columns, 'whose role is to…', '…the Vision at the…', 'Should do/say/own'. Row 1: stakeholders Brad Wasson, Rick Gates, Jeff Koziel, Nimesh Jhaveri | Elizabeth Holmes, Sunny Balwani | Define | Company level | Do:/Say:/Own:. Row 2: Nimesh Jhaveri, Casey Kozlowski, Mahesh Raju | Sunny Balwani, Tracy Masson, Joe Ahdoot, Christian Holmes | Define | Program/ Partnership level | Do:/Say:/Own:. Row 3: Matt Sesto, Brian Sizemore, Casey Kozlowski, Mahesh Raju | Tracy Masson, Kim Alfonso, Joe Ahdoot | Translate and reinforce | Kickoff Market level | Do:/Say:/Own:. Row 4: DMs, RXSs | Sonia Cendejas, Operations Mgrs, Theranos Sales | Translate and reinforce | District level | Do:/Say:/Own:. Row 5: CLs, TIFT Team | Sonia Cendejas, Operations Mgrs | Execute | Community level | Do:/Say:/Own:. Row 6: MGRs, RXMs, Pharmacy Team | Theranos Phlebotomists, Operations Mgrs | Execute | Store level | Do:/Say:/Own:. Row 7: IT, Finance, Call Center, Marketing | Theranos IT, Theranos Call Center | Support | Company, Program, and Field levels | Do:/Say:/Own:. Body rows alternate between #D0DFEE and #E9EFF7 fills with thin white gridlines. No photographs, charts or icons; the red logo mark at bottom left is the only graphic besides the blue band.
Slide 23
An Example: CLs, whose role is to execute the vision of a Superior Patient Experience; support the / Partnership Collaboration and drive Pharmacy Transformation at the Community and Store Level, / should… / Key Stakeholders like… / whose role is to… / …the Vision at the… / Should do/say/own / CLs / MGRs / RXMs / Pharmacy Team / Theranos Phlebotomists / Execute / Store level / Do: / Say: / Own: / CLs, whose role in Theranos is to execute the vision of a Superior Patient Experience and support the Partnership Collaboration at the Community and Store Level, should… / DO: / • Communicate about Theranos services and their benefits in the stores where it is offered; ask team members what they think about the service [Patient Experience, Partnership Collaboration] / • Ensure all the stores in your community are aware of Theranos services and where they are offered [Patient Experience, Partnership Collaboration] / • Regularly update and energize team members - celebrate positive patient experience results in your community [Patient Experience] / • Hold Store Managers in your community accountable for their store-level responsibilities; understand those responsibilities and ask about them on your Store Walks [Partnership Collaboration] / SAY: / • Have you gotten your lipid profile through Theranos yet? What did you think of the service? [Partnership Collaboration] / • (When in non-Theranos stores) Did you see what we are doing over in Store 1234? We can do lab testing services through our Pharmacy there now. Check out this booklet about the service. [Partnership Collaboration] / • I just wanted to recognize the great patient experience Jane provided to one of our Theranos patients. Listen to this great patient feedback! Great job Jane. [Patient Experience] / • John, it looks like there may have been some challenges last week with the bathrooms and having enough Theranos techs during peak time. What do we need to plan for in the next few weeks on scheduling, with immunizations coming up? [Patient Experience, Partnership Collaboration] / OWN: / • Their store’s and community’s Theranos Patient Experience results / • Accountability of their store’s Pharmacy Manager, and of their community’s Store Managers (for pharmacy scheduling, training, store and pharmacy team member engagement and experience) / • Maintain/increase the excitement around the incredible patient experience / Trial Exh. 1884 Page 0039 / ©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only. / 23
Visuals: Table with five body cells and four header cells. Header row (blue cells, white bold Calibri): 'Key Stakeholders like…' spanning columns x 2.2% to 32.2%; 'whose role is to…' x 32.2% to 47.2%; '…the Vision at the…' x 47.2% to 61.2%; 'Should do/say/own' x 61.2% to 98.2%. Body row (light blue cells, black Calibri): x 2.2% to 17.2% 'CLs' (bold), 'MGRs', 'RXMs', 'Pharmacy Team'; x 17.2% to 32.2% 'Theranos Phlebotomists'; x 32.2% to 47.2% 'Execute'; x 47.2% to 61.2% 'Store level'; x 61.2% to 98.2% 'Do:', 'Say:', 'Own:' (bold labels with no entries after them). Logos at lower left, 183 by 38 pixels: a red speech-bubble icon with a white stylised 'w' (Walgreens) followed by an orange-yellow chevron mark and the grey word CHANGE MANAGEMENT in capitals. No photographs, charts or diagrams.
Slide 24
Change Management Updates / Action Planning Exercise Results / Key Anchors Discussion / Readout from Discussion / Next Steps / Execute Against Change Management Action Planning Exercise Results / Leveraging Key Anchors and Action Planning Exercise Results, Finalize FY15 Change / Strategy Draft / Socialize FY15 Change Strategy / Trial Exh. 1884 Page 0040 / ©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only. / 24
Slide 25
W
Diagnostic Testing – Theranos Partnership Program
Measures of Success (SMART Goals)
August 6, 2014
Walgreens
AT THE CORNER OF HAPPY & HEALTHY™
©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.
Trial Exh. 1884 Page 0041
Visuals: Two logos and no photographs or charts. (1) Walgreens W mark: a red (#E4002B) speech-bubble-like square with a white cursive script 'W' and a small 'TM' mark at its lower right, with a dark red (#9B1B26) triangular fold/tail hanging from the lower-left corner. (2) Walgreens corporate logo at bottom right: red (#E31837) script wordmark 'Walgreens' above the tagline 'AT THE CORNER OF' in dark grey (#4D4D4D) capitals, followed by 'HAPPY' in green (#7AC143) and 'HEALTHY' in blue (#5BA3D6) capitals, '&' in dark grey, and a 'TM' superscript at the end of the tagline. No other visual elements.
Slide 26
SMART Program Measures for Success
SMART goals are defined as:
Specific: target a specific area for improvement
Measurable: quantify or at least suggest an indicator of progress
Achievable: realistic and attainable
Realistic: state what results can realistically be achieved, given available resources
Time-related: specify when the result(s) can be achieved
©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.
Trial Exh. 1884 Page 0042
26
Visuals: Logo: the red Walgreens 'W' logo (script 'w' in white inside a red rounded speech-bubble shape with a pointed lower-left tail) at bottom left, about 3.6% wide by 5.0% high, placed at x 6.1%, y 93.3%. No photographs, charts, or diagrams.
Slide 27
SMART Program Measures for Success / Category / Goal / Success Criteria / Owner(s) / Operational / Achieve acceptable labor model / 20 stores with Walgreens / Casey Kozlowski / employed phlebotomist/health / guide by 3/31/15 / Achieve and maintain a training pass rate of / Training pass rate =>90% / 90% by 8/31/15 / Patient Experience / Likelihood to come back by 8/31/15 / =>90% / Referral by friend or family member by / =>20% / 8/31/15 / Capture rate of 47% benchmark / =>47% benchmark / Conversion of non-Walgreens patients to / 10% of the 47% benchmark / become Walgreens patients / ©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only. / Trial Exh. 1884 Page 0043 / 27
Visuals: A table with four columns (Category, Goal, Success Criteria, Owner(s)) and a header row, followed by body rows. Row 1: Category 'Operational'; Goal 'Achieve acceptable labor model'; Success Criteria '20 stores with Walgreens employed phlebotomist/health guide by 3/31/15'; Owner 'Casey Kozlowski'. Row 2: Category blank; Goal 'Achieve and maintain a training pass rate of 90% by 8/31/15'; Success Criteria 'Training pass rate =>90%'; Owner blank. Row 3: Category 'Patient Experience'; Goal 'Likelihood to come back by 8/31/15'; Success Criteria '=>90%'; Owner blank. Row 4: Category blank; Goal 'Referral by friend or family member by 8/31/15'; Success Criteria '=>20%'; Owner blank. Row 5: Category blank; Goal 'Capture rate of 47% benchmark'; Success Criteria '=>47% benchmark'; Owner blank. Row 6: Category blank; Goal 'Conversion of non-Walgreens patients to become Walgreens patients'; Success Criteria '10% of the 47% benchmark'; Owner blank. Header cells are filled #56A0D3 with white bold Calibri; body rows alternate #D0DFEE and #E9EFF7 with white cell gutters between cells. Also a small Walgreens logo at bottom-left: a red speech-bubble shape with a white stylised 'w' mark, about 6% wide.
Slide 28
SMART Program Measures for Success, cont’d
Category
Goal
Success Criteria
Owner(s)
IT
Theranos PSC application uptime =>99%
Note: applicable to DSL connected stores only
Payor and
Providers
Payor coverage of at least 66%
Payor coverage of at least 66%
Financial
Achieve 15* patients/store/day for a store
that has been open at least 3 months by
8/31/15
Achieve 15 patients/store/day
HCC
% of lab orders driven from HCC
This is not being driven due to
steerage
Sunny Balwani/
Pat Carroll
©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.
Trial Exh. 1884 Page 0044
28
Visuals: A table with four columns (Category, Goal, Success Criteria, Owner(s)) and a header row plus four body rows. Header row, bold white Calibri on #56A0D3: Category | Goal | Success Criteria | Owner(s). Row 1: IT | Theranos PSC application uptime =>99% / Note: applicable to DSL connected stores only | (blank) | (blank). Row 2: Payor and Providers | Payor coverage of at least 66% | Payor coverage of at least 66% | (blank). Row 3: Financial | Achieve 15* patients/store/day for a store that has been open at least 3 months by 8/31/15 | Achieve 15 patients/store/day | (blank). Row 4: HCC | % of lab orders driven from HCC | This is not being driven due to steerage | Sunny Balwani/ Pat Carroll. Body rows alternate #D0DFEE and #E9EFF7 with white gutters between cells. The only other graphic is the small red Walgreens speech-bubble logo at bottom left.
Slide 29
Potential Measurable Success Metrics For Stores / Category / Goal / Success Criteria / Owner(s) / Training / % of eligible team members certified to perform / check in / 100% / % of eligible team members certified to perform / 90% / Must work more than 20 hours per week / Must be able to perform service using both hands / Religious reasons / Medical reasons / Position code is: / Perform: RxM, HG, Rx Tech / Check-In Only: SFL, ASMT, ASM, MGR / Action Item: / Need to work with ER to define eligible reasons / % of eligible team members certified to perform finger sticks / ©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only. / Trial Exh. 1884 Page 0045
Visuals: A four-column table with header cells Category, Goal, Success Criteria and Owner(s), all in bold white Calibri on medium blue. Row 1 (light blue fill): Category 'Training'; Goal '% of eligible team members certified to perform check in'; Success Criteria '100%'; Owner(s) blank. Row 2 (pale blue-grey fill): Category blank; Goal '% of eligible team members certified to perform finger sticks'; Success Criteria '90%' followed by a bullet list: 'Must work more than 20 hours per week', 'Must be able to perform service using both hands', 'Religious reasons', 'Medical reasons', 'Position code is:' with two sub-bullets 'Perform: RxM, HG, Rx Tech' and 'Check-In Only: SFL, ASMT, ASM, MGR', then bold 'Action Item:' with bullet 'Need to work with ER to define eligible reasons'; Owner(s) blank. Also a small Walgreens logo at bottom left: a red rounded speech-bubble shape with a white script 'W' and a small red tail at the lower left, 46 by 36 pixels, shown at about 3.6% by 5.0% of the slide.
Slide 30
Potential Measurable Success Metrics For Stores, cntd.
Category
Goal
Success Criteria
Owner(s)
Patient Experience
Patient check in time < X minutes
< 3 minutes
Patient wait + perform time < X minutes
< 7 minutes (between check in end and collection completion)
Survey scores > X
Average star rating per store and by tech
Average % 5 star ratings for 90% of Theranos services
Reduce people who will never come back
95% = yes
Number of sticks needed vs. ideal
>80%
©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.
Trial Exh. 1884 Page 0046
Visuals: A table with four columns and six rows including the header. Header row (Category | Goal | Success Criteria | Owner(s)) on #56A0D3 with white bold Calibri text. Row 1: Category 'Patient Experience'; Goal 'Patient check in time < X minutes'; Success Criteria '< 3 minutes'; Owner(s) blank. Row 2: Category blank; Goal 'Patient wait + perform time < X minutes'; Success Criteria '< 7 minutes (between check in end and collection completion)'; Owner(s) blank. Row 3: Category blank; Goal 'Survey scores > X'; Success Criteria bulleted list: 'Average star rating per store and by tech' and 'Average % 5 star ratings for 90% of Theranos services'; Owner(s) blank. Row 4: Category blank; Goal 'Reduce people who will never come back'; Success Criteria '95% = yes'; Owner(s) blank. Row 5: Category blank; Goal 'Number of sticks needed vs. ideal'; Success Criteria '>80%'; Owner(s) blank. The only other visual is the small red Walgreens logo at bottom left: a red speech-bubble shape with a white stylised 'W' script mark and a dark red tail at the lower left.
Slide 31
Potential Measurable Success Metrics For Stores, cntd.
Category
Goal
Success Criteria
Owner(s)
Patient (non-experience)
Patient volume
Measurement of here’s where / you’re at and here’s where you / are trending
% Venous Draws
<=10% venous draws by 8/31/15
Sunny Balwani
Net New vs. Existing Patients
Note: Need patient name and / zip code (confirm with analytics)
©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.
Trial Exh. 1884 Page 0047
Visuals: A table with four columns headed Category, Goal, Success Criteria and Owner(s). Header row: solid blue #56A0D3 cells with white bold Calibri text, centred. Row 1: Category 'Patient (non-experience)', Goal 'Patient volume', Success Criteria 'Measurement of here’s where you’re at and here’s where you are trending', Owner(s) blank. Row 2: Category blank, Goal '% Venous Draws', Success Criteria '<=10% venous draws by 8/31/15', Owner(s) 'Sunny Balwani'. Row 3: Category blank, Goal 'Net New vs. Existing Patients', Success Criteria 'Note: Need patient name and zip code (confirm with analytics)', Owner(s) blank. Body cell fills alternate: rows 1 and 3 light blue #D0DFEE, row 2 pale #E9EFF7; cells separated by thin white gridlines. Also a small Walgreens logo at bottom left: red #D71F26 speech-bubble shape with a white stylised 'W' script mark.
Slide 32
Diagnostic Testing – Theranos Partnership
Plan for FY15
August 6, 2014
©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.
Trial Exh. 1884 Page 0048
At the corner of HAPPY & HEALTHY™
Visuals: Logo: red Walgreens 'W' mark in a red speech-tab shape with a dark red folded corner tail pointing down-left, with a small TM mark at its right edge. Logo: Walgreens wordmark in red script with the tagline 'AT THE CORNER OF HAPPY & HEALTHY' in grey capitals, with HAPPY in green and HEALTHY in blue, and a TM mark. Background frame: a light blue (#5BA3D4) border surrounds a white panel with rounded corners of about 2% radius. No photographs, charts or diagrams.
Slide 33
Plan for FY15 / • Next market is Northern CA (5 stores initially, then expand for a total of 40) / • Expansion beyond the 5 stores will require Theranos data to obtain store selection / • Next markets? / • IL? IN? TX? FL? / • Plan for FY15 is to follow the Well Experience rollout as much as possible. / • Keeps build-out costs low / • WE personnel are often a good fit for Theranos services. / • Initial goal for FY15 (Sept-Aug) was 500 stores. Need to redefine this goal. / ©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only. / Trial Exh. 1884 Page 0049 / 33
Visuals: Walgreens logo (red speech-bubble shape with white script 'w' letter) at bottom-left, about 46 by 36 pixels, sitting at x 6.1%, y 93.3%, size 3.6% by 5.0%. No charts, photographs or other illustrations.
Slide 34
Diagnostic Testing – Theranos Partnership
California Plans
August 6, 2014
©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.
Trial Exh. 1884 Page 0050
Visuals: Walgreens W logo: a red (#E31837) rounded speech-bubble shape with a darker red (#9E1B24) folded tail at its lower left, with a white script 'W' cut into it and a small TM mark at its upper right. Walgreens tagline logo at bottom right: red script wordmark 'Walgreens' (#E31837) above the line 'AT THE CORNER OF HAPPY & HEALTHY™' in grey capitals (#6D6E71) with 'HAPPY' in green (#8DC63F) and 'HEALTHY' in blue (#5BA3D4). Background frame: a blue (#5BA3D4) full-bleed border with a white rounded-corner panel (corner radius about 3% of slide height) inset about 2.5% from the left and right edges and about 5% from the top and bottom. No photographs, charts or tables.
Slide 35
Theranos California Wave 1: T Minus Schedule
Timing
Target Date
Training event
T-10
8/6
• Finalize California Wave 1 store selection for 4 stores
T-9
8/11-8/22
• Conduct Field Webinars
8/11-8/15
• Assess store readiness and start construction process
T-8
8/11-9/12
• Hire Bots/HG
9/15-10/3
• Complete Bot/HG Training
T-5
9/8-9/26
• Conduct Check-In Training for existing WAG Techs
T-2
9/29-10/3
• Store Manager and Pharmacy Manager expectations/reminder/”coming very soon” Compass communications to stores in the Wave
9/29-10/10
(with copy to DM and RXS)
• TIFT Checklist for Pre-Launch Activities
T-1
10/13-10/17
• Reminder to DMs, RXSs, and CLs in districts/communities with stores going live in the wave: cascade or otherwise communicate to
all stores in your area about new capability in additional stores coming online in one week.
• 5 Minute Meeting scripts to all stores in wave, with instructions on using on or near go-live.
T
(Go Live)
10/21
• MVP recognition via email communications about latest wave of stores going live. Recognition of MGRs, RXMs, Pharmacists, Techs,
and other field personnel involved in stores launching successfully.
• Theranos Go-Live in 4 stores
©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.
Trial Exh. 1884 Page 0051
35
Visuals: Table with three columns and seven data rows, plus header row. Header: Timing | Target Date | Training event. Rows: T-10 | 8/6 | Finalize California Wave 1 store selection for 4 stores. T-9 | 8/11-8/22 and 8/11-8/15 | Conduct Field Webinars; Assess store readiness and start construction process. T-8 | 8/11-9/12 and 9/15-10/3 | Hire Bots/HG; Complete Bot/HG Training. T-5 | 9/8-9/26 | Conduct Check-In Training for existing WAG Techs. T-2 | 9/29-10/3 and 9/29-10/10 | Store Manager and Pharmacy Manager expectations/reminder/”coming very soon” Compass communications to stores in the Wave (with copy to DM and RXS); TIFT Checklist for Pre-Launch Activities. T-1 | 10/13-10/17 | Reminder to DMs, RXSs, and CLs in districts/communities with stores going live in the wave: cascade or otherwise communicate to all stores in your area about new capability in additional stores coming online in one week; 5 Minute Meeting scripts to all stores in wave, with instructions on using on or near go-live. T (Go Live) | 10/21 | MVP recognition via email communications about latest wave of stores going live. Recognition of MGRs, RXMs, Pharmacists, Techs, and other field personnel involved in stores launching successfully; Theranos Go-Live in 4 stores. Row bands alternate: teal tint on T-10, T-8, T-2 and T (Go Live) rows, white on T-9, T-5 and T-1 rows. Logo: Walgreens mark, a red speech-bubble shape with a white script 'w' in the centre, bottom left, about 3.6% wide.
Slide 36
California Theranos Rollout Timeline
2014
July
Aug
Sept
Oct
Store Selection
July 28:
Align on 4
candidate stores
Aug 6:
Finalize 4 locations
w/ Theranos & MP&R
Site Selection
Construction
Assess Store Readiness
Aug 11
Aug 15
Aug 11:
Finalize Design
Elements on D1
Aug 11
Design Elements
Oct 3
Aug 18
Permits
Aug 29
Perform Personnel
Sept 2
Perform Construction
Sept 30
Aug 11
Hiring WAG Personnel
Sept 12
Aug 11
State Regulations (HG & BOP)
Sept 12
Check-In Training
Aug 25
WAG Rx Staff, DH, & MGR
Sept 26
Perform Training
Sept 15
WAG Bot/HG
Oct 3
Sept 8
Check-In & Collection
Training
Sept 26
Communications
Aug 12
Field Webinar
Sept 23
Launch Readiness
Go Live
Oct 21
Trial Exh. 1884 Page 0052
©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.
36
Visuals: Gantt-style timeline diagram with no axis chart. Top bar: a rounded grey (#6A737B) band labelled July, Aug, Sept, Oct in white bold Calibri, spanning x 13.4 to 77.0 percent. Left column: six small pennant arrow shapes pointing right, one per phase: Store Selection teal #75C7B9, Construction purple #B890C2, Perform Personnel grey #6A737B, Check-In Training blue #56A0D3, Perform Training green #7AC143, Communications pink #F07285. Bars with text inside: Site Selection (teal #75C7B9, white label, with two white triangle milestones at about 32 and 40.5 percent x, labelled July 28 and Aug 6); Assess Store Readiness (small purple bar, dates Aug 11 and Aug 15 on either side); Design Elements (purple #B890C2 bar, Aug 11 to Oct 3, with a white triangle milestone at its left end labelled Aug 11: Finalize Design Elements on D1); Permits (purple, Aug 18 to Aug 29); Perform Construction (purple, Sept 2 to Sept 30); Hiring WAG Personnel (orange #FC9D3A, Aug 11 to Sept 12); State Regulations (HG & BOP) (grey #6A737B, Aug 11 to Sept 12); WAG Rx Staff, DH, & MGR (blue #56A0D3, Aug 25 to Sept 26); WAG Bot/HG (green #7AC143, Sept 15 to Oct 3); Check-In & Collection Training (green #7AC143, Sept 8 to Sept 26); Communications bar (pink #F07285, spanning most of the width, with white triangle milestones labelled Aug 12 Field Webinar and Sept 23 Launch Readiness). Red star (#FF0000) at right, containing white bold text Go Live Oct 21, overlapping the right ends of the Perform Construction and Hiring areas. Light grey watermark text 'Confidential – Dates / Subject to Change' in the upper right. Walgreens logo: red speech-bubble shape with a white script 'w', at lower left, 46 by 36 pixels.
Slides 37 to 39 continue in the full text file.
Download this deck
The hosted PDF of every library deck is free for readers of the SlideDeck Co newsletter. Join with your email and the viewer and download appear here.
Preparing a results presentation or business update of your own? The SlideDeck Co Standard Deck is a slide library for business reviews, updates and plans.






